August 18, 2025 · Form 4 insider transaction
Kaye Edward M. MD sold 12,126 shares of Stoke Therapeutics, Inc. at $18.24 per share, a transaction worth $221.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.50 per share, inclusive.